• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Turning Point Therapeutics, Inc. - Common stock (NQ:TPTX)

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 16, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 75.98 (9)
    Ask (Size) 76.00 (7)
    Prev. Close 76.01
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 50,074,277
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics
    From Bristol Myers Squibb
    Via Business Wire
    Blue Chip Stocks In Focus: Bristol-Myers Squibb
    The company has grown earnings by more than 20% per year on average over the last five and ten years. This explosive growth has enabled the company to continue growing its dividend. 
    Via Talk Markets

    Performance

    More News

    Read More
    Recap of Wednesday's Biotech Catalysts - End of The Day Summary
    Via Benzinga
    Analyst Ratings for Turning Point
    Via Benzinga
    Turning Point Secures Positive FDA Feedback For Planned Lung Cancer Drug Submission
    Via Benzinga
    The 3 Best Market Sectors for the Second Half of 2022
    Via InvestorPlace
    TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLP
    Via Business Wire
    TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up
    Via Investor's Business Daily
    INVESTIGATION ALERT: Halper Sadeh LLP Investigates VMW, TPTX, CTT, CTEK
    From Halper Sadeh LLP
    Via AccessWire
    10 Biggest Price Target Changes For Monday
    Via Benzinga
    TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    69 Biggest Movers From Friday
    Via Benzinga
    The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
    Via Benzinga
    The Acquisition of Turning Point Therapeutics By BMY- Bristol- Myers.
    Via Best Stocks
    Mid-Afternoon Market Update: Gold Drops 1%; Sprague Resources Shares Spike Higher
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Mid-Day Market Update: Nasdaq Down 300 Points; Turning Point Therapeutics Shares Jump
    Via Benzinga
    40 Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLP
    Via Business Wire
    CrowdStrike (CRWD) Stock Dips Despite Earnings Beat
    Via InvestorPlace
    TPTX Stock Soars 115% as Bristol Myers Announces Takeover of Turning Point Therapeutics
    Via InvestorPlace
    Mid-Morning Market Update: Markets Open Lower; US Economy Adds 390,000 Jobs In May
    Via Benzinga
    Bristol Myers Snaps Up Turning Point For $4.1 Billion In Cash — Is The Biotech Bear Dead?
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga

    Frequently Asked Questions

    Is Turning Point Therapeutics, Inc. - Common stock publicly traded?
    Yes, Turning Point Therapeutics, Inc. - Common stock is publicly traded.
    What exchange does Turning Point Therapeutics, Inc. - Common stock trade on?
    Turning Point Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Turning Point Therapeutics, Inc. - Common stock?
    The ticker symbol for Turning Point Therapeutics, Inc. - Common stock is TPTX on the Nasdaq Stock Market
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.